Stock Highlights: Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK), Asterias Biotherapeutics, Inc. (NYSEMKT:AST), The Walt Disney Company (NYSE:DIS), Novavax, Inc.

Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) is scheduled to be announcing its Q415 earnings results on Thursday, February 25th. Analysts expect the company to announce earnings of ($0.25) per share and revenue of $31.73 million for the quarter.

Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) belongs to Healthcare sector. Its weekly performance is -10.37%. On last trading day company shares ended up at $5.27. Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) distance from 50-day simple moving average (SMA50) is -7.98%.

Asterias Biotherapeutics, Inc. (NYSEMKT:AST) announced the successful completion of an End-of-Phase 2 meeting with the U.S. Food and Drug Administration (FDA) for AST-VAC1, its investigational therapy targeting acute myeloid leukemia (AML).

Asterias Biotherapeutics, Inc. (NYSEMKT:AST) shares advanced 5.43% in last trading session and ended the day at $3.69. AST Gross Margin is 92.50% and its return on assets is -25.40%. Asterias Biotherapeutics, Inc. (NYSEMKT:AST) quarterly performance is -24.23%.

On 9 February, The Walt Disney Company (NYSE:DIS) in the first fiscal quarter of 2016. “Star Wars: The Force Awakens” drove the Burbank, California, conglomerate to record net income of $2.9 billion for the period ended Jan. 2, 2016, on revenue of $15.2 billion. Per-share earnings rose by more than a third to $1.73.

The Walt Disney Company (NYSE:DIS) shares moved up 0.05% in last trading session and ended the day at $95.43. DIS Gross Margin is 46.00% and its return on assets is 10.30%. The Walt Disney Company (NYSE:DIS) quarterly performance is -20.01%.

Novavax, Inc. (NASDAQ:NVAX) announced it will report its fourth quarter and full year 2015 financial and operating results prior to the open of U.S. financial markets on Monday, February 29, 2016.

Novavax, Inc. (NASDAQ:NVAX) ended the last trading day at $4.79. Company weekly volatility is calculated as 6.82% and price to cash ratio as 4.46. Novavax, Inc. (NASDAQ:NVAX) showed a weekly performance of -5.52%.

Union Bankshares Corporation (NASDAQ:UBSH) announced that Robert M. Gorman, executive vice president and chief financial officer, and Bill Cimino, vice president and director of corporate communications, will present at the Raymond James 37th Annual Institutional Investors Conference at the JW Marriott Grande Lakes Hotel, 4040 Central Florida Parkway in Orlando on Tuesday, March 8, 2016. The presentation is scheduled for approximately 2:15 p.m. Eastern Standard Time.

Union Bankshares Corporation (NASDAQ:UBSH) shares decreased -0.09% in last trading session and ended the day at $22.20. UBSH return on assets is 0.90%. Union Bankshares Corporation (NASDAQ:UBSH) quarterly performance is -15.06%.

Leave a Reply

Your email address will not be published. Required fields are marked *